JP2011504108A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504108A5
JP2011504108A5 JP2010534507A JP2010534507A JP2011504108A5 JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5 JP 2010534507 A JP2010534507 A JP 2010534507A JP 2010534507 A JP2010534507 A JP 2010534507A JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5
Authority
JP
Japan
Prior art keywords
peptide
phe
fusion protein
cancer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010534507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504108A (ja
JP5385910B2 (ja
Filing date
Publication date
Priority claimed from ES200703052A external-priority patent/ES2328776B1/es
Application filed filed Critical
Publication of JP2011504108A publication Critical patent/JP2011504108A/ja
Publication of JP2011504108A5 publication Critical patent/JP2011504108A5/ja
Application granted granted Critical
Publication of JP5385910B2 publication Critical patent/JP5385910B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010534507A 2007-11-19 2008-11-14 スクルフィンに結合する能力を有するペプチドおよびその用途 Expired - Fee Related JP5385910B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200703052 2007-11-19
ES200703052A ES2328776B1 (es) 2007-11-19 2007-11-19 Peptidos con capacidad para unirse a escurfina y aplicaciones.
PCT/ES2008/000716 WO2009065982A1 (es) 2007-11-19 2008-11-14 Péptidos con capacidad para unirse a escurfina y aplicaciones

Publications (3)

Publication Number Publication Date
JP2011504108A JP2011504108A (ja) 2011-02-03
JP2011504108A5 true JP2011504108A5 (enExample) 2012-01-12
JP5385910B2 JP5385910B2 (ja) 2014-01-08

Family

ID=40409793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010534507A Expired - Fee Related JP5385910B2 (ja) 2007-11-19 2008-11-14 スクルフィンに結合する能力を有するペプチドおよびその用途

Country Status (11)

Country Link
US (1) US8524860B2 (enExample)
EP (1) EP2223998B1 (enExample)
JP (1) JP5385910B2 (enExample)
CN (1) CN101903514B (enExample)
AU (1) AU2008327792B2 (enExample)
BR (1) BRPI0819311A2 (enExample)
CA (1) CA2706201A1 (enExample)
ES (1) ES2328776B1 (enExample)
MX (1) MX2010005520A (enExample)
RU (1) RU2502741C2 (enExample)
WO (1) WO2009065982A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080518B2 (en) * 2007-12-05 2011-12-20 Arbor Vita Corporation Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
CA3018494C (en) 2009-06-10 2021-12-07 Nono Inc. Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
CA2939711C (en) * 2014-02-21 2020-09-29 Cellectis Method for in situ inhibition of regulatory t cells
ES2665543B1 (es) * 2016-10-26 2019-02-12 Fundacion Para La Investig Medica Aplicada Péptidos de unión a FOXP3 y usos de los mismos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698015A (en) * 1995-05-19 1997-12-16 Nikko Company Conductor paste for plugging through-holes in ceramic circuit boards and a ceramic circuit board having this conductor paste
EP1037911A4 (en) * 1997-12-10 2003-07-23 Univ Washington ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF
ATE495255T1 (de) * 1998-08-11 2011-01-15 Darwin Discovery Ltd Identifikation des gens das zum schorfigen phenotyp der maus führt, sowie seines menschlichen orthologs
WO2001059115A2 (en) * 2000-02-09 2001-08-16 Agensys, Inc. 83p5g4: a tissue specific protein highly expressed in prostate cancer
US20030191073A1 (en) * 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
ATE405586T1 (de) * 2001-05-08 2008-09-15 Darwin Molecular Corp Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins
WO2006044864A2 (en) * 2004-10-19 2006-04-27 Duke University Vaccine adjuvant
US20100061984A1 (en) * 2006-01-20 2010-03-11 The Trustees Of The University Of Pennsylvania Compositions and methods for modulation of suppressor t cell activation

Similar Documents

Publication Publication Date Title
JP2017538682A5 (enExample)
JP2008538183A5 (enExample)
JP2010540453A5 (enExample)
JP2019512478A5 (enExample)
JP2008525033A5 (enExample)
FI3393510T3 (fi) Zika-virusrokote
JP2020525429A5 (enExample)
JP2006512300A5 (enExample)
JP2008505985A5 (enExample)
JP2012505657A5 (enExample)
JP2011504108A5 (enExample)
JP2001518304A5 (enExample)
JP2005502663A5 (enExample)
JP2014525939A5 (enExample)
JP2014510699A5 (enExample)
JP2011139704A5 (enExample)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
RU2010125199A (ru) Пептиды со способностью связываться со скурфином и их применение
JP2012512633A5 (enExample)
RU2010125695A (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
CN105646626B (zh) 一种高收率索氟布韦的合成方法
CN109415410B (zh) 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗
JP2007511534A5 (enExample)
JP2011512336A5 (enExample)
US10662155B2 (en) Methods of preparing tecovirimat